New Rhein Healthcare Investors to sell stake in Softhale

New Rhein Healthcare Investors has agreed to sell its 60 percent stake in Softhale to Sino Biopharmaceutical Limited for an upfront payment of $110 million plus a profit share.

23 March 2021•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles